4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000013
Chief Medical Officer sold 417 shares at $27.59 ($11,505)
- Chief Medical Officer acquired 417 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-02-17 | Option exercise 10b5-1 | +417 | $15.44 | $6,438 | 44,506 | D |
| Rodman David Malcom Chief Medical Officer | 2026-02-17 | Sale 10b5-1 | −417 | $27.59 | $11,505 | 44,089 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-02-17 | Option exercise · Stock Option 10b5-1 | −417 | 5,417 | D | ||
| Open-market sales · 417 sh · avg $27.59 · $11,505 | |||||||
Loading xslF345X05/wk-form4_1771372594.xml…